Advertisement
Letter to the Editor| Volume 99, ISSUE 1, P70, January 2019

How soon is too soon or watch the donut not the hole

      Edelman AB et al. are to be congratulated for reporting the results of yet another well designed, meaningful study — this time studying the impact early administration of oral contraceptives might have on the ability of ulipristal acetate to delay ovulation [
      • Edelman A.B.
      • Jensen J.T.
      • McCrimmon S.
      • Messerle-Forbes M.
      • O'Donnell A.
      • Hennebold J.
      Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: a prospective cohort study.
      ]. The only concern I have is with the paper's conclusion: “This study demonstrates that UPA's efficacy as an emerging contraceptive is reduced with early exposure to COC.”
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Edelman A.B.
        • Jensen J.T.
        • McCrimmon S.
        • Messerle-Forbes M.
        • O'Donnell A.
        • Hennebold J.
        Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: a prospective cohort study.
        Contraception. 2018; 98: 463-466